A 12 weeks, randomized, double-blind, placebo-controlled human trial of Omija extract mixture on improvement of Hyperglycemia

A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Omija extract mixture on improvement of Hyperglycemia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006613

Enrollment

Registered

2021-09-28

Start date

2021-02-02

Completion date

Unknown

Last updated

2021-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : • Omija extract mixture group: Twice a day, 2 capsules once, after breakfast and dinner, for 12 weeks(1.4 g/day, 0.5 g/day for Omija extract mixture) • Placebo group: Twice a day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Males and females aged over 19 years and under 70 years at the screening examination 2) Fasting blood glucose=100 mg/dL and <140 mg/dL 3) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions

Exclusion criteria

Exclusion criteria: 1) Patients who need care of diabetes at the screening examination. 2) Patients who take medicine for glucose and intake health functional food within 3 months prior to the screening examination. 3) Patients with a history of medicine or alcohol abuse 4) Patients who have participated in other clinical trials within 3 months prior to the screening examination

Design outcomes

Primary

Measure	Time frame
fasting glucose;postprandial glucose	—

Secondary

Measure	Time frame
Insulin; HbA1c(Hemoglobin A1c);lipid profile;C-peptide	—

Countries

Korea, Republic of

Contacts

Public ContactSoo jung Park

Woosuk University Korean Medicine Medical Center

taorgi@hanmail.net+82-63-220-8676

Outcome results